Trademark: 86278128
Word
ENVISION PHARMA GROUP
Status
Registered
Status Code
702
Status Date
Saturday, October 16, 2021
Serial Number
86278128
Registration Number
4775303
Registration Date
Tuesday, July 21, 2015
Mark Type
4000
Filing Date
Monday, May 12, 2014
Published for Opposition
Tuesday, May 5, 2015

Trademark Owner History
ENVISION PHARMA INC. - Original Registrant

Classifications
35 Strategic business consulting services for the life science, pharmaceutical and bio-pharmaceutical industries in the field of health economics and outcomes research; Strategic business marketing consulting services for the life science, pharmaceutical and bio-pharmaceutical industries in the field of market access communication strategies; Strategic business consulting services for the life science, pharmaceutical and bio-pharmaceutical industries in the field of medical and scientific publication planning
41 Strategic educational consulting services for the life sciences, pharmaceutical and bio-pharmaceutical industries in the field of medical education, namely, continuing professional educational courses and meetings for Medical Science Liaisons
42 Medical and scientific publication planning in the nature of technical writing for others related to pharmaceutical and bio-pharmaceutical products; Design and implementation of software and technology solutions for the life science, pharmaceutical and bio-pharmaceutical industries, for the purpose of creating, communicating, reporting and auditing of scientific information to be publicly disclosed; Design and implementation of software and technology solutions for the life science, pharmaceutical and bio-pharmaceutical industries, for use in grant programs that manages investigator sponsored research, product requests, funding requests, donation requests, decision process workflow, activity monitoring, and management of contractual obligations
45 Strategic consulting services for the life science, pharmaceutical and bio-pharmaceutical industries in the nature of regulatory compliance consulting in the field of pharmaceutical and bio-pharmaceutical products
Page 1, In the statement, line 1, "," should be deleted.
"PHARMA GROUP"

Trademark Events
Oct 16, 2021
Notice Of Acceptance Of Sec. 8 & 15 - E-Mailed
Oct 16, 2021
Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.
Oct 16, 2021
Case Assigned To Post Registration Paralegal
Jul 7, 2021
Teas Section 8 & 15 Received
Jul 21, 2020
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Dec 13, 2019
Correction Under Section 7 ¿ Processed
Dec 13, 2019
Case Assigned To Post Registration Paralegal
Nov 7, 2019
Teas Section 7 Request Received
Nov 7, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 7, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 7, 2019
Teas Change Of Correspondence Received
Nov 7, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 7, 2019
Teas Change Of Owner Address Received
Jul 21, 2015
Registered-Principal Register
May 5, 2015
Official Gazette Publication Confirmation E-Mailed
May 5, 2015
Published For Opposition
Apr 15, 2015
Notification Of Notice Of Publication E-Mailed
Mar 27, 2015
Law Office Publication Review Completed
Mar 27, 2015
Assigned To Lie
Mar 8, 2015
Approved For Pub - Principal Register
Feb 24, 2015
Teas/Email Correspondence Entered
Feb 24, 2015
Correspondence Received In Law Office
Feb 24, 2015
Teas Response To Office Action Received
Sep 3, 2014
Notification Of Non-Final Action E-Mailed
Sep 3, 2014
Non-Final Action E-Mailed
Sep 3, 2014
Non-Final Action Written
Aug 26, 2014
Assigned To Examiner
May 22, 2014
New Application Office Supplied Data Entered In Tram
May 15, 2014
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24